Form 8-K - Current report:
SEC Accession No. 0001193125-25-159400
Filing Date
2025-07-15
Accepted
2025-07-15 16:50:41
Documents
15
Period of Report
2025-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d42277d8k.htm   iXBRL 8-K 70719
2 EX-99.1 d42277dex991.htm EX-99.1 17162
6 GRAPHIC g42277g0715190612385.jpg GRAPHIC 1658
7 GRAPHIC g42277g45v38.jpg GRAPHIC 14895
  Complete submission text file 0001193125-25-159400.txt   248239

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ikna-20250715.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20250715_lab.xml EX-101.LAB 19501
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20250715_pre.xml EX-101.PRE 12169
17 EXTRACTED XBRL INSTANCE DOCUMENT d42277d8k_htm.xml XML 3899
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 251125333
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)